---
layout: default
title: A Fully Transformer Based Multimodal Framework for Explainable Cancer Image Segmentation Using Radiology Reports
---

# A Fully Transformer Based Multimodal Framework for Explainable Cancer Image Segmentation Using Radiology Reports

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.13796" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.13796v1</a>
  <a href="https://arxiv.org/pdf/2508.13796.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.13796v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.13796v1', 'A Fully Transformer Based Multimodal Framework for Explainable Cancer Image Segmentation Using Radiology Reports')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Enobong Adahada, Isabel Sassoon, Kate Hone, Yongmin Li

**åˆ†ç±»**: cs.CV, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-08-19

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºMed-CTXä»¥è§£å†³ä¹³è…ºç™Œè¶…å£°å›¾åƒåˆ†å‰²çš„å¯è§£é‡Šæ€§é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `å¤šæ¨¡æ€èåˆ` `å¯è§£é‡Šæ€§` `åŒ»å­¦å›¾åƒåˆ†å‰²` `æ·±åº¦å­¦ä¹ ` `å˜æ¢å™¨` `ä¸´åºŠæ–‡æœ¬` `è¶…å£°å›¾åƒ` `è®¡ç®—æœºè¾…åŠ©è¯Šæ–­`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„åŒ»å­¦å›¾åƒåˆ†å‰²æ–¹æ³•åœ¨å¯è§£é‡Šæ€§å’Œæ€§èƒ½ä¸Šå­˜åœ¨ä¸è¶³ï¼Œå°¤å…¶æ˜¯åœ¨ä¹³è…ºç™Œè¶…å£°å›¾åƒçš„å¤„ç†ä¸Šã€‚
2. è®ºæ–‡æå‡ºçš„Med-CTXæ¡†æ¶é€šè¿‡ç»“åˆä¸´åºŠæ”¾å°„å­¦æŠ¥å‘Šå’ŒåŒåˆ†æ”¯è§†è§‰ç¼–ç å™¨ï¼Œæå‡äº†åˆ†å‰²çš„ç²¾ç¡®æ€§å’Œå¯è§£é‡Šæ€§ã€‚
3. åœ¨BUS-BRAæ•°æ®é›†ä¸Šï¼ŒMed-CTXçš„Diceå¾—åˆ†è¾¾åˆ°99%ï¼ŒIoUä¸º95%ï¼Œæ˜¾è‘—è¶…è¶Šäº†U-Netã€ViTå’ŒSwinç­‰åŸºçº¿æ¨¡å‹ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æˆ‘ä»¬ä»‹ç»äº†Med-CTXï¼Œè¿™æ˜¯ä¸€ç§å®Œå…¨åŸºäºå˜æ¢å™¨çš„å¤šæ¨¡æ€æ¡†æ¶ï¼Œç”¨äºå¯è§£é‡Šçš„ä¹³è…ºç™Œè¶…å£°åˆ†å‰²ã€‚é€šè¿‡æ•´åˆä¸´åºŠæ”¾å°„å­¦æŠ¥å‘Šï¼ŒMed-CTXåœ¨æ€§èƒ½å’Œå¯è§£é‡Šæ€§ä¸Šå‡æœ‰æ‰€æå‡ã€‚è¯¥æ¡†æ¶é‡‡ç”¨åŒåˆ†æ”¯è§†è§‰ç¼–ç å™¨ï¼Œç»“åˆViTå’ŒSwinå˜æ¢å™¨ï¼Œä»¥åŠä¸ç¡®å®šæ€§æ„ŸçŸ¥èåˆï¼Œå®ç°äº†ç²¾ç¡®çš„ç—…ç¶æç»˜ã€‚ä¸´åºŠè¯­è¨€é€šè¿‡BioClinicalBERTè¿›è¡Œç¼–ç ï¼Œå¹¶åˆ©ç”¨è·¨æ¨¡æ€æ³¨æ„åŠ›ä¸è§†è§‰ç‰¹å¾ç»“åˆï¼Œä½¿æ¨¡å‹èƒ½å¤Ÿæä¾›ä¸´åºŠåŸºç¡€çš„ç”Ÿæˆè§£é‡Šã€‚æˆ‘ä»¬çš„ç ”ç©¶åŒæ—¶ç”Ÿæˆåˆ†å‰²æ©è†œã€ä¸ç¡®å®šæ€§å›¾å’Œè¯Šæ–­ç†ç”±ï¼Œå¢å¼ºäº†è®¡ç®—æœºè¾…åŠ©è¯Šæ–­çš„ä¿¡å¿ƒå’Œé€æ˜åº¦ã€‚åœ¨BUS-BRAæ•°æ®é›†ä¸Šï¼ŒMed-CTXçš„Diceå¾—åˆ†è¾¾åˆ°99%ï¼ŒIoUä¸º95%ï¼Œè¶…è¶Šäº†ç°æœ‰çš„åŸºçº¿æ¨¡å‹U-Netã€ViTå’ŒSwinã€‚ä¸´åºŠæ–‡æœ¬åœ¨åˆ†å‰²ç²¾åº¦å’Œè§£é‡Šè´¨é‡ä¸­èµ·åˆ°äº†å…³é”®ä½œç”¨ï¼Œæ¶ˆèç ”ç©¶è¡¨æ˜ï¼Œç¼ºå°‘ä¸´åºŠæ–‡æœ¬ä¼šå¯¼è‡´Diceå¾—åˆ†ä¸‹é™5.4%ï¼ŒCIDErä¸‹é™31%ã€‚Med-CTXå®ç°äº†è‰¯å¥½çš„å¤šæ¨¡æ€å¯¹é½ï¼ˆCLIPå¾—åˆ†ï¼š85%ï¼‰å’Œå¢å¼ºçš„ç½®ä¿¡åº¦æ ¡å‡†ï¼ˆECEï¼š3.2%ï¼‰ï¼Œä¸ºå¯ä¿¡èµ–çš„å¤šæ¨¡æ€åŒ»å­¦æ¶æ„è®¾å®šäº†æ–°çš„æ ‡å‡†ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬è®ºæ–‡æ—¨åœ¨è§£å†³ä¹³è…ºç™Œè¶…å£°å›¾åƒåˆ†å‰²ä¸­çš„å¯è§£é‡Šæ€§é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•å¾€å¾€ç¼ºä¹å¯¹ä¸´åºŠèƒŒæ™¯çš„ç†è§£ï¼Œå¯¼è‡´åˆ†å‰²ç»“æœéš¾ä»¥è§£é‡Šå’Œä¿¡ä»»ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šMed-CTXé€šè¿‡æ•´åˆä¸´åºŠæ”¾å°„å­¦æŠ¥å‘Šä¸è§†è§‰ä¿¡æ¯ï¼Œåˆ©ç”¨åŒåˆ†æ”¯è§†è§‰ç¼–ç å™¨å’Œè·¨æ¨¡æ€æ³¨æ„åŠ›æœºåˆ¶ï¼Œæå‡äº†åˆ†å‰²çš„ç²¾åº¦å’Œå¯è§£é‡Šæ€§ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥æ¡†æ¶åŒ…æ‹¬åŒåˆ†æ”¯è§†è§‰ç¼–ç å™¨ï¼ˆç»“åˆViTå’ŒSwinå˜æ¢å™¨ï¼‰ã€BioClinicalBERTç”¨äºç¼–ç ä¸´åºŠæ–‡æœ¬ï¼Œä»¥åŠä¸ç¡®å®šæ€§æ„ŸçŸ¥èåˆæ¨¡å—ï¼Œæ•´ä½“æµç¨‹ä¸ºï¼šè¾“å…¥å›¾åƒå’Œæ–‡æœ¬ â†’ ç‰¹å¾æå– â†’ è·¨æ¨¡æ€èåˆ â†’ ç”Ÿæˆåˆ†å‰²æ©è†œå’Œè§£é‡Šã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ€é‡è¦çš„åˆ›æ–°åœ¨äºå°†ä¸´åºŠæ–‡æœ¬ä¸è§†è§‰ç‰¹å¾çš„ç»“åˆï¼Œé€šè¿‡è·¨æ¨¡æ€æ³¨æ„åŠ›æœºåˆ¶å®ç°äº†æ›´é«˜çš„åˆ†å‰²ç²¾åº¦å’Œå¯è§£é‡Šæ€§ã€‚è¿™ä¸€è®¾è®¡ä½¿å¾—æ¨¡å‹èƒ½å¤Ÿç”ŸæˆåŸºäºä¸´åºŠçš„è§£é‡Šï¼ŒåŒºåˆ«äºä¼ ç»Ÿæ–¹æ³•ã€‚

**å…³é”®è®¾è®¡**ï¼šæ¨¡å‹ä½¿ç”¨çš„æŸå¤±å‡½æ•°åŒ…æ‹¬åˆ†å‰²æŸå¤±å’Œä¸ç¡®å®šæ€§æŸå¤±ï¼Œç½‘ç»œç»“æ„é‡‡ç”¨åŒåˆ†æ”¯è®¾è®¡ï¼Œç¡®ä¿è§†è§‰ç‰¹å¾å’Œæ–‡æœ¬ç‰¹å¾çš„æœ‰æ•ˆèåˆã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

Med-CTXåœ¨BUS-BRAæ•°æ®é›†ä¸Šå–å¾—äº†æ˜¾è‘—çš„æ€§èƒ½ï¼ŒDiceå¾—åˆ†è¾¾åˆ°99%ï¼ŒIoUä¸º95%ï¼Œè¶…è¶Šäº†U-Netã€ViTå’ŒSwinç­‰ç°æœ‰åŸºçº¿æ¨¡å‹ã€‚æ­¤å¤–ï¼Œæ¶ˆèç ”ç©¶è¡¨æ˜ï¼Œç¼ºå°‘ä¸´åºŠæ–‡æœ¬ä¼šå¯¼è‡´Diceå¾—åˆ†ä¸‹é™5.4%ï¼ŒCIDErä¸‹é™31%ï¼Œæ˜¾ç¤ºå‡ºä¸´åºŠæ–‡æœ¬åœ¨æ¨¡å‹ä¸­çš„é‡è¦æ€§ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬åŒ»å­¦å½±åƒåˆ†æã€è®¡ç®—æœºè¾…åŠ©è¯Šæ–­å’Œä¸ªæ€§åŒ–åŒ»ç–—ã€‚é€šè¿‡æä¾›å¯è§£é‡Šçš„åˆ†å‰²ç»“æœï¼ŒMed-CTXèƒ½å¤Ÿå¸®åŠ©åŒ»ç”Ÿæ›´å¥½åœ°ç†è§£å’Œä¿¡ä»»æ¨¡å‹çš„å†³ç­–ï¼Œä»è€Œæé«˜ä¸´åºŠè¯Šæ–­çš„æ•ˆç‡å’Œå‡†ç¡®æ€§ã€‚æœªæ¥ï¼Œè¯¥æ¡†æ¶æœ‰æœ›æ‰©å±•åˆ°å…¶ä»–ç±»å‹çš„åŒ»å­¦å›¾åƒåˆ†æä»»åŠ¡ä¸­ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> We introduce Med-CTX, a fully transformer based multimodal framework for explainable breast cancer ultrasound segmentation. We integrate clinical radiology reports to boost both performance and interpretability. Med-CTX achieves exact lesion delineation by using a dual-branch visual encoder that combines ViT and Swin transformers, as well as uncertainty aware fusion. Clinical language structured with BI-RADS semantics is encoded by BioClinicalBERT and combined with visual features utilising cross-modal attention, allowing the model to provide clinically grounded, model generated explanations. Our methodology generates segmentation masks, uncertainty maps, and diagnostic rationales all at once, increasing confidence and transparency in computer assisted diagnosis. On the BUS-BRA dataset, Med-CTX achieves a Dice score of 99% and an IoU of 95%, beating existing baselines U-Net, ViT, and Swin. Clinical text plays a key role in segmentation accuracy and explanation quality, as evidenced by ablation studies that show a -5.4% decline in Dice score and -31% in CIDEr. Med-CTX achieves good multimodal alignment (CLIP score: 85%) and increased confi dence calibration (ECE: 3.2%), setting a new bar for trustworthy, multimodal medical architecture.

